AUG 08, 2015 5:56 PM PDT

Bench to Bedside

WRITTEN BY: Ilene Schneider
Researchers Amber Southwell, Michael Hayden and Blair Leavitt at the University of British Columbia Centre for Molecular Medicine and Therapeutics and the Centre for Huntington Disease in Canada have developed a new test that enables physicians to measure the effects of gene silencing therapy in Huntington's disease. The researchers, who worked with colleagues from the Mayo Clinic, will support the first human clinical trial of a drug that targets the genetic cause of the disease. The gene silencing therapy is designed to reduce the levels of a toxic protein in the brain that causes Huntington's disease, as published in Scientific Reports and reported in Drug Discovery & Development (http://www.dddmag.com/news/2015/08/scientists-develop-test-measure-effectiveness-treatments-huntingtons-disease?et_cid=4724062&et_rid=45505806&location=top).
Blair Leavitt of UBC's Centre for Molecular Medicine and Therapeutics , one of the developers of the test
As explained by the American Speech-Language-Hearing Association (ASHA), Huntington's disease (HD) is a genetic disorder characterized by progressive degeneration of brain cells. Most individuals with Huntington's disease develop some signs and symptoms by the time they reach their 30s or 40s. The effects of Huntington's disease include difficulty in motor control (movement), cognition (thinking) and behavior. Sometimes people with HD will the same areas of difficulty throughout the course of the disease, with varying severity. Motor problems in HD include impairments in voluntary movements and uncontrolled involuntary jerking or writhing movements (chorea). Individuals with HD usually experience have muscle problems, such as rigidity or muscle contracture (dystonia), in addition to impaired gait, posture and balance. Motor control problems give those with HD trouble performing daily activities and remaining independent. There can be speech and swallowing problems when the centers of motor or cognitive control responsible for these functions are affected (http://www.asha.org/public/speech/disorders/HuntingtonsDisease.htm).

According to Leavitt, "This is an important breakthrough for several promising gene silencing therapies in Huntington's disease that are now moving from the bench to the bedside. We can move forward with these clinical trials and accurately measure whether our treatments are working."

The genetic mutation that causes HD produces a toxic form of a protein called huntingtin, which progressively damages brain cells. By lowering the brain levels of this toxic protein, researchers hope to prevent or delay the onset of HD symptoms. Several huntingtin-lowering therapies have demonstrated great potential in animal models and are quickly approaching clinical trials in humans.

The team found a way to determine the levels of mutant huntingtin protein in the brain by collecting cerebrospinal fluid from a spinal tap. The ultrasensitive test is designed to detect small amounts of the toxic protein. The test can be used to track changes in brain levels of the protein over time in response to new drugs.

Because of this study, Leavitt can initiate a new clinical trial of a huntingtin gene-silencing therapy for patients at the Centre for Huntington Disease at the Djavad Mowafaghian Centre for Brain Health, a partnership between UBC and Vancouver Coastal Health. This trial, which will test the safety of a novel gene-silencing treatment in patients and is already in the process of screening patient candidates, will be the first human study of a drug targeting mutant huntingtin.
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
JUL 08, 2021
Cannabis Sciences
High-potency Cannabis Impacts Memory, but not Decision-Making
JUL 08, 2021
High-potency Cannabis Impacts Memory, but not Decision-Making
High-potency cannabis products impair memory in various ways, according to new research published in Scientific Rep ...
AUG 03, 2021
Neuroscience
A Tree Falls in the Forest: A Neuroscientist on the World Our Brain Creates
AUG 03, 2021
A Tree Falls in the Forest: A Neuroscientist on the World Our Brain Creates
Neuroscientist, Donald Hoffman, thinks a mathematical model will solve the hard problem of consciousness
AUG 05, 2021
Neuroscience
Mice Control 'Feel Good' Chemical Dopamine in Their Brains
AUG 05, 2021
Mice Control 'Feel Good' Chemical Dopamine in Their Brains
Mice are both aware of random dopamine signaling in their brains and can willfully control it, according to new research ...
AUG 31, 2021
Coronavirus
Researchers Use Newer Approach to Analyze Long Haul COVID-19 and Post Traumatic Stress Symptoms
AUG 31, 2021
Researchers Use Newer Approach to Analyze Long Haul COVID-19 and Post Traumatic Stress Symptoms
fMRI of some COVID-19 survivors suffering from posttraumatic stress symptoms reveal altered functional brain connectivit ...
SEP 05, 2021
Microbiology
Gut Bacteria May Influence Infant Brain Development
SEP 05, 2021
Gut Bacteria May Influence Infant Brain Development
Our health is closely connected to the community of microbes we carry in our gut. For example, these microbes have a pow ...
SEP 21, 2021
Health & Medicine
The (Not So) Secret To A Happy Life: Fruits, Vegetables, and Exercise
SEP 21, 2021
The (Not So) Secret To A Happy Life: Fruits, Vegetables, and Exercise
Researchers uncover causal link between a healthy lifestyle and satisfaction with life.
Loading Comments...